NCT06904365 Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06789172 A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06710756 Lead-212 PSV359 Therapy for Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06580002 Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Status RECRUITING Phase PHASE2
NCT06476704 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas Status NOT_YET_RECRUITING Phase PHASE2
NCT06113315 A Study Involving Collection of Samples and Data From Sarcoma Patients Receiving Immunotherapy Status ENROLLING_BY_INVITATION Phase N/A
NCT06103669 Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) Status RECRUITING Phase NA
NCT05708950 A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) Status COMPLETED Phase PHASE1/PHASE2
NCT05334069 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection Status RECRUITING Phase N/A
NCT05253131 Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas Status NOT_YET_RECRUITING Phase PHASE2
NCT05130255 GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 Status TERMINATED Phase PHASE1
NCT05106777 Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04673942 A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04457258 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT03896620 Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma Status ACTIVE_NOT_RECRUITING Phase N/A